Crinone Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

The adverse reactions reported below are classified according to frequency of occurrence as follows: Very common (≤ 1/10), Common (≤ 1/100 to < 1/10), Uncommon (≤ 1/1,000 to < 1/100), Rare (≤ 1/10,000 to < 1/1,000), Very rare (< 1/10,000).
Crinone is generally well tolerated. In clinical studies, the following adverse events have been reported during Crinone therapy. Most adverse events observed in clinical studies cannot be distinguished from the symptoms common in early pregnancy.
Common: Breast tenderness, itching or burning.
Post Marketing Reports: For adverse reactions identified during post-marketing surveillance, the frequency is not known (cannot be estimated from the available data).
In addition, intermenstrual bleeding (spotting), hypersensitivity reactions usually manifesting as skin rash, vaginal irritation and other mild application site reactions have been reported post marketing.

View ADR Monitoring Form

progesterone

Manufacturer:

Merck

Distributor:

Apex Pharma Marketing